Search results
Results From The WOW.Com Content Network
COVID-19 pandemic. IndoVac is a recombinant protein subunit COVID-19 vaccine, [1][2] developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas. [1][2] It is the world's first officially halal certified COVID-19 vaccine, [3] but the most popular existing vaccines had already been widely endorsed as ...
How COVID‑19 vaccines work. The video shows the process of vaccination, from injection with RNA or viral vector vaccines, to uptake and translation, and on to immune system stimulation and effect. Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths ...
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [45][46] It is authorized for use ...
CoronaVac, also known as the Sinovac COVID-19 vaccine, [4] was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. [5][6] It was phase III clinically trialled in Brazil, [7] Chile, [8] Indonesia, [9] the Philippines, [10] and Turkey [11] and relies on traditional technology similar to other inactivated ...
The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. [ 1 ] The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. [31] It contains a recombinant spike protein from the SARS-CoV-2 Omicron variant lineage JN.1.
The Janssen COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID‑19 in people aged eighteen years and older. [36][1] The vaccine is given by intramuscular injection into the deltoid muscle. The initial course consists of a single dose.